Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $731,400 - $948,450
-15,000 Closed
0 $0
Q3 2017

Oct 06, 2017

BUY
$55.23 - $63.74 $828,450 - $956,100
15,000
15,000 $956,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Axel Capital Management, LLC Portfolio

Follow Axel Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axel Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axel Capital Management, LLC with notifications on news.